Previous 10 | Next 10 |
2023-11-15 00:33:34 ET Summary Harrow is a company focused on eye health with a strong distribution platform and CEO ownership. Q3 earnings were below expectations, and guidance was lowered, raising concerns about operational performance. However, the company has lots of oppor...
2023-11-14 14:22:16 ET Gainers: BioCardia ( BCDA ) +170% . reAlpha Tech Corp. ( AIRE ) +119% . Turnstone Biologics Corp ( TSBX ) +75% . Theseus Pharmaceuticals ( THRX ) +49% . American Coastal Insurance Corp ( ACIC ) +38% . M...
2023-11-14 13:31:57 ET More on Harrow Health Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Implications Of Harrow's Short-Term Guidance Harrow Health's 5-Year Guidance Biggest stock movers today: Home Depot, Fisker, Snap, Beauty Health Company and more...
2023-11-14 08:10:54 ET More on pre-market losers Financial information for Collective Audience, Inc. Financial information for E-Home Household For further details see: EJH and CAUD among pre-market losers
2023-11-14 05:00:20 ET Related stories: The Beauty Health Company (SKIN) Q3 2023 Earnings Call Transcript Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Fisker, Inc. (FSR) Q3 2023 Earnings Call Transcript For further details see: Biggest stock mover...
2023-11-13 21:25:23 ET Harrow, Inc. (HROW) Q3 2023 Earnings Conference Call November 13, 2023 16:45 ET Corporate Participants Jamie Webb - Director-Communications & Investor Relations Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer ...
2023-11-13 18:01:34 ET Gainers: Theseus Pharmaceuticals ( THRX ) +35% . GENFIT ( GNFT ) +15% . Lifeway Foods ( LWAY ) +9% . Digital World Acquisition ( DWACW ) +8% . Digital World Acquisition ( DWAC ) +5% . Lose...
2023-11-13 16:08:09 ET More on Harrow Health Implications Of Harrow's Short-Term Guidance Harrow Health's 5-Year Guidance Seeking Alpha’s Quant Rating on Harrow Health Historical earnings data for Harrow Health Financial information for Harrow ...
Third Quarter 2023 and Recent Selected Highlights: Record revenues of $34.3 million, an increase of 50% over $22.8 million in the prior-year quarter and an increase of 2% over $33.5 million in the sequential quarter. GAAP net loss of $(4.4 million). Adjusted EBITDA of $9.2 million, ...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
News, Short Squeeze, Breakout and More Instantly...
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that its management team would attend the 2024 American Society of Retina Specialists (ASRS) Annual Meeting, taking place in Stockholm, Sweden, from July 17-20, 2024. The ASRS Annual Meeting brings tog...
Contract Enhances Purchasing Power for 340B Prime Vendor Program (PVP) Participants; Aligns with Harrow’s Mission to Make Its Products Accessible and Affordable Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that as of July 1, 2024, ...